| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.30B | +46.1% |
| Cost of Revenue | $871.4M | +24.9% |
| Gross Profit | $429.1M | +123.3% |
| R&D Expense | $43.6M | +17.5% |
| SG&A Expense | $124.1M | +76.9% |
| Operating Income | -$399.0M | -3057.3% |
| Pre-tax Income | -$477.7M | — |
| Income Tax | $39.4M | +1530.9% |
| Net Income | -$517.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.2M | +43.9% |
| Short-term Investments | $10.5M | -86.4% |
| Accounts Receivable | $342.4M | +129.5% |
| Current Assets | $530.4M | +54.6% |
| Total Assets | $1.33B | +141.8% |
| Current Liabilities | $484.1M | +67.2% |
| Long-term Debt | $605.1M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.6M | -88.9% |
| Capital Expenditures | $5.6M | -24.0% |
| Investing Cash Flow | -$554.2M | -925.3% |
| Financing Cash Flow | $585.3M | +597.3% |
| Free Cash Flow | $2.0M | -96.7% |
| — |
| EPS (Basic) | -$5.69 | — |
| EPS (Diluted) | -$5.69 | -5072.7% |
| Total Liabilities |
| $1.23B |
| +287.7% |
| Stockholders' Equity | $95.4M | -58.7% |